Lv1
20 积分 2025-05-25 加入
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
16小时前
已完结
Triglyceride-Glucose Index: A Candidate Prognostic Marker in HR-Positive/HER2-Negative Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors
3个月前
已完结
Increased pretreatment triglyceride glucose-body mass index associated with poor prognosis in patients with advanced non-small cell lung cancer
3个月前
已完结
The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
3个月前
已完结
Triglyceride-Glucose Index: A Candidate Prognostic Marker in HR-Positive/HER2-Negative Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors
3个月前
已关闭
Increased pretreatment triglyceride glucose-body mass index associated with poor prognosis in patients with advanced non-small cell lung cancer
4个月前
已完结
Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population-based study
4个月前
已完结
Prediabetes and the risk of breast cancer: a meta-analysis
5个月前
已完结
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review
7个月前
已完结
Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor-Positive Breast Cancer
7个月前
已完结
皖公网安备34019202002308
